JW Holdings
JW홀딩스 · 096760
Financials Diversified Financials · KOSPI
Market cap US$196.6M (₩271.3B)
Overview
JW Holdings is a holding company, a firm that owns and oversees a group of subsidiaries, whose underlying businesses produce pharmaceutical ingredients, finished medicines, and medical devices.
It sits at the top of that corporate structure, earning income through subsidiary dividends, brand-licensing fees, administrative services provided to affiliates, and by handling overseas business for the raw materials and finished products its subsidiaries make. Listed on KOSPI, Korea's main stock exchange, it also directly manages international sales activities on behalf of its subsidiary and grandchild companies.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$672.5M
- FY2024US$643.3M
- FY2025US$702.6M
Operating profit
- FY2023US$105M
- FY2024US$106.2M
- FY2025US$121.7M
Net income
- FY2023US$22.5M
- FY2024US$89M
- FY2025US$83.7M
Key ratios (FY2025)
Why it matters
JW Holdings was spun off from JW Jungwoe Pharmaceutical as a separate holding company and later renamed JW Holdings, a structure common among larger Korean corporate groups.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?